Asimov
Intelligent design of living systems
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Business Model
- SaaS
- Website
- asimov.com
- Total Funding
- $175.0M
- Last Round
- $175.0M Series BJan 2023
- Rounds
- 1
About
Asimov builds an integrated platform of cells, genes, and cloud-based design software to enable advanced genetic design and biomanufacturing for biologics, cell therapies, and gene therapies. It provides GMP host cells, genetic parts libraries, and AI-driven tools for therapeutic production.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Jan 2023
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...